Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hippocrates VC is a venture capital firm established in July 2018, based in the United States. The firm was founded as a physician-funded social impact digital therapeutics venture capital fund, focusing on healthcare-related technologies. The firm aims to enhance patient outcomes and improve healthcare delivery through strategic investments in early-stage digital health startups.
Currently, Hippocrates VC manages a fund size of $10 million and has invested in three notable portfolio companies. The firm is distinct in the venture capital landscape as it is exclusively funded by physician investors, which provides a unique alignment between investment and healthcare expertise. This model allows Hippocrates VC to offer not only capital but also clinically informed diligence and post-investment support to its portfolio companies.
Hippocrates VC specializes in the digital therapeutics and health technology sectors. The firm seeks to invest in early-stage companies that are developing evidence-based solutions aimed at improving healthcare delivery and patient experiences. Their investment thesis emphasizes supporting innovations that enhance patient outcomes, particularly in the realms of chronic disease prevention and treatment.
The firm primarily focuses on seed-stage investments within the United States, particularly in New York. While specific check sizes have not been disclosed, the firm’s historical focus on seed funding indicates a preference for early investments that can leverage the clinical insights of its physician investors. Hippocrates VC is particularly interested in companies that align with its mission of improving healthcare delivery through technology.
Hippocrates VC has invested in three notable companies within the healthcare sector:
Laurence Girard - Managing Director: Laurence Girard founded Hippocrates VC and has a background in healthcare entrepreneurship. He previously served as the CEO and founder of Fruit Street, a telehealth platform that offers the CDC's diabetes prevention program. His expertise lies in raising physician-backed capital and guiding healthcare startups through the investment process.
To pitch Hippocrates VC, founders should visit their website at hippocratesvc.com. A detailed pitch deck is recommended, including information on the technology, market analysis, and evidence of clinical outcomes. The firm prefers to receive pitches through their website, and founders should expect a response within a few weeks.
Warm introductions are beneficial but not mandatory. Founders should ensure that their pitch clearly aligns with Hippocrates VC's focus on healthcare-related technologies and digital therapeutics.
As of April 2026, Hippocrates VC has not reported any recent investment activity since its launch in 2018. The firm’s last verified investment was in December 2018, when it participated in the seed financing of Avive AED. Founders should verify the current status of the fund and its investment activity before pursuing a partnership.
What are Hippocrates VC's investment criteria?
Hippocrates VC focuses on early-stage investments in healthcare-related technologies, particularly in digital therapeutics and health technology. They seek companies that develop evidence-based solutions aimed at improving patient outcomes and healthcare delivery.
How can I pitch to Hippocrates VC?
Founders interested in pitching to Hippocrates VC should visit their website at hippocratesvc.com for application details. A well-prepared pitch deck should include information about the technology, market potential, and how the solution improves patient outcomes.
What makes Hippocrates VC different from other investors?
Hippocrates VC is unique as it is exclusively funded by physician investors, providing a distinct advantage in terms of clinical insights and support for portfolio companies. This model enhances the firm's ability to conduct informed diligence and offer valuable post-investment assistance.
What is the geographic focus of Hippocrates VC?
The firm primarily invests in the United States, with a historical emphasis on New York. This geographic focus allows them to leverage local healthcare networks and resources.
What is the typical check size for investments?
While specific check sizes have not been disclosed, Hippocrates VC has historically focused on seed-stage investments, which typically range from $100,000 to $1 million.
What kind of support can portfolio companies expect?
Portfolio companies benefit from Hippocrates VC's network of physician investors, which provides not only capital but also clinical expertise and guidance throughout the investment process. This support can enhance the chances of success in the healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.